Intraocular manifestations of systemic DLBCL are rare and there are no data about intraocular manifestations of high-grade B-cell lymphoma with MYc and BCL6 rearrangements. This evidence concerns the gene BCL6 and B-cell non-Hodgkin lymphoma.